TVB-2640/ASC-41

N/A

Report date: 2023/05/22 10:19:18
NME

Base Information

Drug NameTVB-2640/ASC-41
Drug Alias NameASC-40/ASC-41
ClassificationSmall molecules
Mechanisms of ActionThyroid hormone receptor beta-1 agonistsFatty acid synthase inhibitors
TargetsFatty acid synthaseThyroid hormone receptor beta
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGannex Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGannex Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A